Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia

Blood

Volumn 92, Issue 11, 1998, Pages 4279-4286

  Frankel, Arthur E ^a   Lilly, Michael ^b   Kreitman, Robert ^b   Hogge, Donna ^b   Beran, Miloslav ^b   Freedman, Melvin H ^b   Emanuel, Peter D ^b   McLain, Chris ^b   Hall, Philip ^b   Tagge, Edward ^b   Berger, Marc ^b   Eaves, Connie ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; DRUG CONJUGATION; FEMALE; HUMAN; HUMAN CELL; INFANT; LIGAND BINDING; MALE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ADULT; AGED; CELL DEATH; CHILD, PRESCHOOL; DIPHTHERIA TOXIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; TUMOR STEM CELLS;

EID: 0032400865     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Cambier N, Baruchel A, Schlageter MH, Menot ML, Wattel E, Fenaux P, Chomienne C: Chronic myelomonocytic leukemia: From biology to therapy. Hematol Cell Ther 39:41, 1997
2. Heryll A, Derigs G: Chronic myelomonocytic leukaemia: Clinical data, morphological features, and outcome in 56 patients. Haematol Blood Transfus 33:387, 1990
3. Arico M, Biondi A, Pui CH: Juvenile myelomonocytic leukemia. Blood 90:479, 1997
4. Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Horbott J, Hasle H Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van Wering E, Zimmerman M: Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases. Blood 89:3534, 1997
5. Frankel AE, Hall PD, Burbage C, Vesely J, Willingham M, Bhalla K, Kreitman RJ: Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein. Blood 90:3654, 1997
6. Hogge DE, Willman CL, Kreitman RJ, Hall PD, Kopecky KJ, McLain C, Tagge E, Frankel AE: Blasts from patients with previously untreated acute myeloid leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony stimulating factor (GMCSF) fusion protein. Blood 92:589, 1998
7. Lansdorp PM, Dragowska W: Longterm erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med 175:1501, 1992
8. Conneally E, Eaves CJ, Humphries RK: Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 91:3487, 1998
9. Oertel J, Oertel B, Beyer J, Huhn D: CD34 immunotyping of blasts in myelodysplasia. Ann Hematol 68:77, 1994
10. Ralph P, Ho MK, Litcofsky PB, Springer TA: Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol 130:108, 1983
11. Ralph P, Nakoinz I: Direct toxic effects of immunopotentiators on monocytic, myelomonocytic and histiocytic or macrophage tumor cells in culture. Cancer Res 37:546, 1977
12. Polotskaya A, Zhao Y, Lilly M, Kraft A: A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor receptor in mediating cell growth. Cell Growth Differ 4:523, 1993
13. Crosier KE, Wang GG, Mathyey-Prevot B, Nathan DG, Sieff CA: A functional isoform of the human granulocyte-macrophage colony-stimulating factor receptor contains a unique cytoplasmic domain. Proc Natl Acad Sci USA 88:7744, 1991
14. Polotskaya A, Zhao Y, Lilly MB, Kraft AS: Mapping the intracytoplasmic regions of the alpha granulocyte-macrophage colony stimulating factor receptor necessary for cell growth regulation. J Biol Chem 269:14607, 1994
15. Mizushima S, Nagata S: pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322, 1990
16. Miller AD, Rosman G: Improved retroviral vector for gene transfer and expression. Biotechniques 7:980, 1989
17. Kreitman RJ, Pastan I: Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either Pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Blood 90:242, 1997
18. Rayappa C, McCulloch EA: A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside. Leukemia 7:992, 1993
19. Frankel AE, Hall PD, McLain C, Safa AR, Tagge EP, Kreitman RJ: Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF. Bioconjug Chem 9:490, 1998
20. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C, Cox C: The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Br J Haematol 87:746, 1994
21. Hasle H, Kerndrup G: Atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia in children, Br J Haematol 89:428, 1996
22. McKinstry WJ, Li CL, Rasko JE, Nicola NA, Johnson GR, Metcalf D: Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65, 1997
23. Testa U, Pelosi E, Gabbianelli M, Fossati C, Campisi S, Isacchi G, Peschle C: Cascade transactivation of growth factor receptors in early human hematopoiesis. Blood 81:1442, 1993
24. Terpstra W, Rozemuller H, Breems D, Rombouts E, Prins A, FitzGerald DJ, Kreitman RJ, Wielenga JJ, Ploemacher RE, Lowenberg B, Hagenbeek A, Martens ACM: Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hematopoietic stem cells. Blood 90:3735, 1997
25. Bendel AE, Shao Y, Davies SM, Warman B, Yang C, Waddick K, Uckun F, Perentesis JP: A recombinant fusion toxin targeted to the granulocyte -macrophage colony-stimulating factor receptor. Leuk Lymphoma 25:257, 1997
26. Chan C, Blazar B, Eide C, Kreitman RJ, Vallera DA: A murine cytokine fusion toxin specifically targeting the murine granulocytemacrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells. Blood 86:2732, 1995
27. Emanuel PD, Zhu SW, Bates LJ, Zuckennan KS: Hypersensitivity to hematopoietic growth factors in chronic myelomonocytic leukemia (CMML) Blood 78:156a, 1991 (suppl 1)
28. Tagge E, Harris B, Burbage C, Hall P, Vesely J, Willingham M, Frankel AE: Synthesis of green fluorescent protein-ricin and monitoring of its intracellular trafficking. Bioconjug Chem 8:743, 1997
29. Bradbury D, Zhu Y, Russell N: Bcl2 expression in acute myeloid leukemia: Relationship with autonomous growth and CD34 antigen expression. Leuk Lymphoma 24:221, 1997
30. Bonati A, Albertini R, Garau D, Pinelli S, Lunghi P, Almici C, Carlo-Stella C, Rizzoli V. Dall'Aglio P: Bcl2 oncogene protein expression in human hematopoietic precursors during fetal life. Exp Hematol 24:459, 1996
31. Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd RL, Homans A, Chaffee S, Nitschke R, Gualtieri RJ: A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 331:1680, 1994
32. Zuckerman KS, Emanuel PD, Hu X: Molecular pathophysiology of juvenile chronic myeloid leukemia, in Abraham NG, Marks PA, Konwalinka G, Sachs L, TavassoliM(eds): Molecular Biology of Hematopoiesis 1992 (vol 2). Intercept Scientific, Medical and Technical Publications, Andover, Hampshire, England, 1992, p 533
33. Freeburn R, Gale R, Wagner H, Linch D: Analysis of the coding sequence for the GM-CSF receptor α and β chains in patients with juvenile chronic myeloid leukemia (JCML) Exp Hematol 25:306, 1997
34. Castleberry RP, Chang M, Maybee D, Emanuel PD: A phase II study of 13-cis-Retinoic Acid (CRA) in juvenile myelomonocytic leukemia (JMML). A Pediatric Oncology Group (POG) study. Blood 90:346a, 1997 (abstr, suppl 1)
35. Wattel E, Guerci A, Economopoulos T, Copplestone A, Mahe B. Couteaux M, Resegotti L, Voglova V, Foussard C, Pegourie B, Michaux J, Deconinck E, Stoppa A, Mufti G, Oscier D, Fenaux P: A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Blood 88:2480, 1996
36. Beran M, Kantarjian H, O'Brien S, Koller C, Al-Bitar M, Arbuck S, Pierce S, Moore M, Abbruzzese J, Andreeff M, Keating M, Estey E: Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 88:2473, 1996
37. Cambier N, Wattel E, Menot M, Guerci A, Chomienne C, Fenaux P: All-trans retinioic acid in adult chronic myelomonocytic leukemia: Results of a pilot study. Leukemia 10:1164, 1996